Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 08, 2022

Retrobulbar Injection of Amphotericin B in Patients With COVID-19–Associated Orbital Mucormycosis

Ophthalmic Plastic and Reconstructive Surgery

 

Additional Info

Ophthalmic Plastic and Reconstructive Surgery
Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review
Ophthalmic Plast Reconstr Surg 2022 Sep 01;38(5)425-432, A Sharifi, Z Akbari, M Shafie'ei, N Nasiri, M Sharifi, M Shafiei, A Zand

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading